NOvel Biomarkers of LEwy body dementia (NOBLE)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2005469

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Lewy body dementia is a common yet under-recognised form of dementia in older people. There is a great need for biomarkers to reduce misdiagnosis and improve outcomes for patients and families. Recently there have been exciting advances in research regarding blood tests that might improve diagnosis and understanding of dementia. We will study these blood markers of neurodegeneration and inflammation in people with Lewy body dementia, which may improve diagnosis and help discover new treatments.

Funded Activity Details

Start Date: 01-01-2020

End Date: End date not available

Funding Scheme: Postgraduate Scholarships

Funding Amount: $132,743.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | dementia | neurodegenerative disorders | prognostic markers

Related Links